Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.

Published

Journal Article

Hepatic steatosis, the accumulation of lipids in the liver, is widely believed to result in insulin resistance. To test the causal relationship between hepatic steatosis and insulin resistance, we generated mice that overexpress acyl-CoA:diacylglycerol acyltransferase 2 (DGAT2), which catalyzes the final step of triacylglycerol (TG) biosynthesis, in the liver (Liv-DGAT2 mice). Liv-DGAT2 mice developed hepatic steatosis, with increased amounts of TG, diacylglycerol, ceramides, and unsaturated long-chain fatty acyl-CoAs in the liver. However, they had no abnormalities in plasma glucose and insulin levels, glucose and insulin tolerance, rates of glucose infusion and hepatic glucose production during hyperinsulinemic-euglycemic clamp studies, or activities of insulin-stimulated signaling proteins in the liver. DGAT1 overexpression in the liver also failed to induce glucose or insulin intolerance. Our results indicate that DGAT-mediated lipid accumulation in the liver is insufficient to cause insulin resistance and show that hepatic steatosis can occur independently of insulin resistance.

Full Text

Duke Authors

Cited Authors

  • Monetti, M; Levin, MC; Watt, MJ; Sajan, MP; Marmor, S; Hubbard, BK; Stevens, RD; Bain, JR; Newgard, CB; Farese, RV; Hevener, AL

Published Date

  • July 2007

Published In

Volume / Issue

  • 6 / 1

Start / End Page

  • 69 - 78

PubMed ID

  • 17618857

Pubmed Central ID

  • 17618857

International Standard Serial Number (ISSN)

  • 1550-4131

Digital Object Identifier (DOI)

  • 10.1016/j.cmet.2007.05.005

Language

  • eng

Conference Location

  • United States